Back
Zevra Therapeutics, Inc. 10K Form
Sell
39
ZVRA
Zevra Therapeutics, Inc.
Last Price:
$8.65
Seasonality Move:
-2.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ZVRA News And Ratings
See the #1 stock for the next 7 days that we like better than ZVRA
ZVRA Financial Statistics
Sales & Book Value
| Annual Sales: | $23.6M |
|---|---|
| Cash Flow: | $4.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.37 |
| Price / Book: | 3.66 |
Profitability
| EPS (TTM): | 0.63080 |
|---|---|
| Net Income (TTM): | $35.3M |
| Gross Margin: | $3.6M |
| Return on Equity: | 44.06% |
| Return on Assets: | 16.53% |
Zevra Therapeutics, Inc. Earnings Forecast
Key Zevra Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for ZVRA is 15.12%.
-
The Selling, General & Administrative Expenses for ZVRA have been equal to 232.37% of Gross Profit Margin.
-
The Research & Development expenses have been 151.22% of Revenue.
-
The Net Earning history of ZVRA is -446.85% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 5 years.
Zevra Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ZVRA |
| Website: | zevra.com |
Debt
| Debt-to-Equity Ratio: | 0.47 |
|---|---|
| Current Ratio: | 8.62 |
| Quick Ratio: | 8.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 13.97 |
ZVRA Technical Analysis vs Fundamental Analysis
Sell
39
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Is Zevra Therapeutics, Inc. a Buy or a Sell?
-
Zevra Therapeutics, Inc. stock is rated a SellThe current Zevra Therapeutics, Inc. [ZVRA] share price is $8.66. The Score for ZVRA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.